Back to search results

HeartLogic Diagnostic for Congestive Heart Failure

This study is looking at whether using a special tool called the HeartLogic Diagnostic can help people with chronic congestive heart failure (a condition where the heart can't pump enough blood) and a low ejection fraction (EF, meaning the heart pumps out less blood than it should). The study will compare two groups: one where the HeartLogic tool's alert threshold is changed, and another where it stays the same. The main goal is to see if using this tool can reduce how often people need to be hospitalized. You might be able to join if you are 18 or older, have an EF of 35% or less, and have had a recent hospitalization or worsening heart failure symptoms. The current recruitment status is unclear.

Study design
This is an interventional, randomized study involving 135 participants. It compares two groups: one with a changed HeartLogic threshold and one with an unchanged threshold.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed to measure hospitalizations at 365 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07412626

Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
Robert Pickett
~135 participants
Updated 2026-02-17 on ClinicalTrials.gov
What's tested:Heartlogic Diagnostic Tool Threshold ChangeHeartlogic Diagnostic Tool Unchanged Threshold

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hospitalizations
Measured over 365 Days

Conditions

Congestive Heart Failure Chronic
Low Ejection Fraction

Explore related trials

Heart Failure

NCT07412626

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Ascension St. Vincent Medical Group

    Indianapolis, Indianastudy coordinator listed

  • Saint Thomas Heart at Saint Thomas Midtown

    Nashville, Tennesseestudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Robert Pickett, MD · PRINCIPAL_INVESTIGATOR · Ascension Health

Who to contact

Robert Pickett, MD
[email protected]
615-329-5144
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
EF \</=35%
Prior hospitalization within the last two years or prior decompensation to NYHA class III or IV over the last 12 months that was treated without hospitalization
HeartLogic capable ICD or CRT-D (Patients with HeartLogic capable ICD or CRT-D can be enrolled at time of de novo implantation or generator change out or at the time of the 2 week wound check. Prior Heart logic capable ICF or CRT-D implants can be enrolled if heart failure hospitalization shows decompensation within six months (prior implants must have at least 1 year battery life)

Exclusion

Refuse to give consent
Have Life expectancy of less than one-year
Documented noncompliance that limits medication use
Patients on Dialysis (renal insufficiency but not on dialysis is NOT an exclusion)
Pregnancy

What this trial measures

  • Hospitalizations365 Days

    Number of Hospitalizations